Hjem › Alzheimers sykdom › Connecticut
Kliniske studier for Alzheimers sykdom i Connecticut
12 studier for Alzheimers sykdom søker deltakere på steder i Connecticut.
Byer i Connecticut
Offisiell studietekst (engelsk)
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Ki Health Partners, LLc, dba New England Institute for Clinical Research, Stamford
RekruttererFase 2
Alder 55 til 85 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07589595A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- University of Connecticut Health Center, Farmington
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06585787Music for Pain and Dementia
- Connecticut Mental Health Clinic, New Haven
Rekrutterer
Alder 50 til 80 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07602283Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Yale University, New Haven
RekruttererFase 3
Alder 50 til 90 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Local Institution - 2632, Norwalk
RekruttererFase 3
Alder 55 til 90 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07011745Exploring the Utility of [18F]3F4AP for Demyelination Imaging
- Yale University PET Center, New Haven
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 18 til 90 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06999434A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Yale University, Alzheimer's Disease Research Unit ( Site 1059), New Haven
RekruttererFase 2
Alder 50 til 85 · Alle kjønn · Oppdatert 26. aug. 2026 · NCT07033494Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Yale University School of Medicine - Section of Cardiology, New Haven
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Yale University School of Medicine, New Haven
RekruttererFase 2/3Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Yale University School of Medicine, New Haven
RekruttererFase 2/3Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05552157Neurologic Stem Cell Treatment Study
- MD Stem Cells, Westport
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 26. jun. 2026 · NCT02795052Evaluation of a Mobile App Program for Coping With Cancer
- Smilow Cancer Hospital, New Haven
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 15. jun. 2026 · NCT06923501Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.